Mergers & Acquisitions Mergers & Acquisitions

Comment: New transatlantic regulatory working group on pharma deals may help harmonize reviews while bringing 'aggressive' approach

By Natalie McNelis and Flavia Fortes
  • 16 Mar 2021 15:50
  • 25 Mar 2021 09:46
A new transatlantic working group for mergers in the pharmaceutical sector will provide an opportunity to build on existing cooperation among regulators in the US, UK, Canada and the European Union to help harmonize analysis, which has sometimes diverged in recent global deals. The unified process is good news for parties, but

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

TAKE A FREE TRIAL

Latest News